CARD9 versus CARMA1 in innate and adaptive immunity

Trends in Immunology

Volumn 30, Issue 5, 2009, Pages 234-242

  Hara, Hiromitsu ^a   Saito, Takashi ^b,c  

^a SAGA UNIVERSITY   (Japan)

^b RIKEN Center for Integrative Medical Sciences   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CARD CONTAINING MAGUK PROTEIN 1; CASPASE 8; CASPASE RECRUITMENT DOMAIN PROTEIN 9; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; FC RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; APOPTOSIS; B CELL LYMPHOMA 10 GENE; BONE MARROW CELL; CARCINOGENESIS; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE STRUCTURE; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOID CELL; MACROPHAGE; MOUSE; MUCOSA ASSOCIATED LYMPHOID TISSUE 1 GENE; NONHUMAN; OLIGOMERIZATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TUMOR GENE; UBIQUITINATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIBODY FORMATION; CARD SIGNALING ADAPTOR PROTEINS; GUANYLATE CYCLASE; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE;

EID: 65449139593     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2009.03.002     Document Type: Review

References (74)

1. Isakov N. Role of immunoreceptor tyrosine-based activation motif in signal transduction from antigen and Fc receptors. Adv. Immunol. 69 (1998) 183-247
2. Samelson L.E. Signal transduction mediated by the T cell antigen receptor: the role of adapter proteins. Annu. Rev. Immunol. 20 (2002) 371-394
3. Wegener E., and Krappmann D. CARD-Bcl10-Malt1 signalosomes: missing link to NF-κB. Sci. STKE 384 (2007) pe21
4. Hara H., et al. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat. Immunol. 8 (2007) 619-629
5. Hara H., et al. Cell type-specific regulation of ITAM-mediated NF-κB activation by the adaptors. CARMA1 and CARD9. J. Immunol. 181 (2008) 918-930
6. Gross O., et al. Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-κB and MAPK activation to selectively control cytokine production. Blood 112 (2008) 2421-2428
7. Thome M. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nat. Rev. Immunol. 4 (2004) 348-359
8. Bertin J., et al. CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10/CLAP and activates NF-κB. J. Biol. Chem. 275 (2000) 41082-41086
9. Che T., et al. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-κB activation. J. Biol. Chem. 279 (2004) 15870-15876
10. McCully R.R., and Pomerantz J.L. The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-κB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association. Mol. Cell. Biol. 28 (2008) 5668-5686
11. Wang D., et al. A requirement for CARMA1 in TCR-induced NF-κB activation. Nat. Immunol. 3 (2002) 830-835
12. Ruland J., et al. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-κB and neural tube closure. Cell 104 (2001) 33-42
13. Ruland J., et al. Differential requirement for Malt1 in T and B cell antigen receptor signaling. Immunity 19 (2003) 749-758
14. Hara H., et al. The MAGUK family protein CARD11 is essential for lymphocyte activation. Immunity 18 (2003) 763-775
15. Ruefli-Brasse A.A., et al. Regulation of NF-κB-dependent lymphocyte activation and development by paracaspase. Science 302 (2003) 1581-1584
16. Blonska M., et al. The CARMA1-Bcl10 signaling complex selectively regulates JNK2 kinase in the T cell receptor-signaling pathway. Immunity 26 (2007) 55-66
17. Xue L., et al. Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells. Nat. Immunol. 4 (2003) 857-865
18. Pappu B.P., and Lin X. Potential role of CARMA1 in CD40-induced splenic B cell proliferation and marginal zone B cell maturation. Eur. J. Immunol. 36 (2006) 3033-3043
19. Oliver A.M., et al. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur. J. Immunol. 27 (1997) 2366-2374
20. Humphrey M.B., et al. Role of ITAM-containing adapter proteins and their receptors in the immune system and bone. Immunol. Rev. 208 (2005) 50-65
21. Robinson M.J., et al. Myeloid C-type lectins in innate immunity. Nat. Immunol. 7 (2006) 1258-1265
22. Yamasaki S., et al. Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat. Immunol. 9 (2008) 1179-1188
23. Brown G.D. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat. Rev. Immunol. 6 (2006) 33-43
24. Taylor P.R., et al. Dectin-1 is required for β-glucan recognition and control of fungal infection. Nat. Immunol. 8 (2007) 31-38
25. Saijo S., et al. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat. Immunol. 8 (2007) 39-46
26. Gross O., et al. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 442 (2006) 651-656
27. Young S.H., et al. Molecular mechanism of tumor necrosis factor-α production in 1→3-β-glucan (zymosan)-activated macrophages. J. Biol. Chem. 276 (2001) 20781-20787
28. Gantner B.N., et al. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. 197 (2003) 1107-1117
29. Rogers N.C., et al. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 22 (2005) 507-517
30. Liu Y., et al. BCL10 mediates lipopolysaccharide/toll-like receptor-4 signaling through interaction with Pellino2. J. Biol. Chem. 279 (2004) 37436-37444
31. Dong W., et al. The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-κB from Toll-like receptor 4. J. Biol. Chem. 281 (2006) 26029-26040
32. Goodridge H.S., et al. Differential use of CARD9 by Dectin-1 in macrophages and dendritic cells. J. Immunol. 182 (2009) 1146-1154
33. Hsu Y.M., et al. The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens. Nat. Immunol. 8 (2007) 198-205
34. Lanier L.L. NK cell recognition. Annu. Rev. Immunol. 23 (2005) 225-274
35. Malarkannan S., et al. Bcl10 plays a divergent role in NK cell-mediated cytotoxicity and cytokine generation. J. Immunol. 179 (2007) 3752-3762
36. Schulze-Luehrmann J., and Ghosh S. Antigen-receptor signaling to nuclear factor κB. Immunity 25 (2006) 701-715
37. Rawlings D.J., et al. The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes. Nat. Rev. Immunol. 6 (2006) 799-812
38. Sommer K., et al. Phosphorylation of the CARMA1 linker controls NF-κB activation. Immunity 23 (2005) 561-574
39. Matsumoto R., et al. Phosphorylation of CARMA1 plays a critical role in T cell receptor-mediated NF-κB activation. Immunity 23 (2005) 575-585
40. Stilo R., et al. Physical and functional interaction of CARMA1 and CARMA3 with Iκ kinase γ-NFκB essential modulator. J. Biol. Chem. 279 (2004) 34323-34331
41. 2+/calmodulin-dependent protein kinase II is a modulator of CARMA1-mediated NF-κB activation. Mol. Cell. Biol. 26 (2006) 5497-5508
42. Zeng H., et al. Phosphorylation of Bcl10 negatively regulates T-cell receptor-mediated NF-κB activation. Mol. Cell. Biol. 27 (2007) 5235-5245
43. 2+/calmodulin-dependent protein kinase II. Mol. Immunol. 44 (2007) 2095-2100
44. Shinohara H., et al. IκB kinase β-induced phosphorylation of CARMA1 contributes to CARMA1 Bcl10 MALT1 complex formation in B cells. J. Exp. Med. 204 (2007) 3285-3293
45. Wegener E., et al. Essential role for IκB kinase β in remodeling Carma1-Bcl10-Malt1 complexes upon T cell activation. Mol. Cell 23 (2006) 13-23
46. Lobry C., et al. Negative feedback loop in T cell activation through IκB kinase-induced phosphorylation and degradation of Bcl10. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 908-913
47. Bidere N., et al. Casein kinase 1α governs antigen-receptor-induced NF-κB activation and human lymphoma cell survival. Nature 458 (2008) 92-96
48. Yang H., et al. pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-κB agonist Card9 by CK2. Mol. Cell 28 (2007) 15-27
49. Tanner M.J., et al. CARMA1 coiled-coil domain is involved in the oligomerization and subcellular localization of CARMA1 and is required for T cell receptor-induced NF-κB activation. J. Biol. Chem. 282 (2007) 17141-17147
50. Jun J.E., et al. Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. Immunity 18 (2003) 751-762
51. Thome M. Multifunctional roles for MALT1 in T-cell activation. Nat. Rev. Immunol. 8 (2008) 495-500
52. Sun L., et al. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell 14 (2004) 289-301
53. Wu C.J., and Ashwell J.D. NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated NF-κB activation. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 3023-3028
54. Oeckinghaus A., et al. Malt1 ubiquitination triggers NF-κB signaling upon T-cell activation. EMBO J. 26 (2007) 4634-4645
55. Uren A.G., et al. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol. Cell 6 (2000) 961-967
56. Rebeaud F., et al. The proteolytic activity of the paracaspase MALT1 is key in T cell activation. Nat. Immunol. 9 (2008) 272-281
57. Coornaert B., et al. T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-κB inhibitor A20. Nat. Immunol. 9 (2008) 263-271
58. Salmena L., et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev. 17 (2003) 883-895
59. Su H., et al. Requirement for caspase-8 in NF-κB activation by antigen receptor. Science 307 (2005) 1465-1468
60. Chau H., et al. Cellular FLICE-inhibitory protein is required for T cell survival and cycling. J. Exp. Med. 202 (2005) 405-413
61. Kawadler H., et al. The paracaspase MALT1 controls caspase-8 activation during lymphocyte proliferation. Mol. Cell 31 (2008) 415-421
62. Wang D., et al. CD3/CD28 costimulation-induced NF-κB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IκB kinase β to the immunological synapse through CARMA1. Mol. Cell. Biol. 24 (2004) 164-171
63. Misra R.S., et al. Caspase-8 and c-FLIPL associate in lipid rafts with NF-κB adaptors during T cell activation. J. Biol. Chem. 282 (2007) 19365-19374
64. Hara H., et al. The molecular adapter Carma1 controls entry of IκB kinase into the central immune synapse. J. Exp. Med. 200 (2004) 1167-1177
65. Medeiros R.B., et al. Regulation of NF-κB activation in T cells via association of the adapter proteins ADAP and CARMA1. Science 316 (2007) 754-758
66. Lee K.Y., et al. PDK1 nucleates T cell receptor-induced signaling complex for NF-κB activation. Science 308 (2005) 114-118
67. Park S.G., et al. The kinase PDK1 integrates T cell antigen receptor and CD28 coreceptor signaling to induce NF-κB and activate T cells. Nat. Immunol. 10 (2009) 158-166
68. Du M.Q. MALT lymphoma: recent advances in aetiology and molecular genetics. J. Clin. Exp. Hematop. 47 (2007) 31-42
69. Holzmann K., et al. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes. Cancer Res. 64 (2004) 4428-4433
70. Sanchez-Izquierdo D., et al. MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma. Blood 101 (2003) 4539-4546
71. Dijkman R., et al. Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma. J. Clin. Oncol. 24 (2006) 296-305
72. Shen L., et al. Aberrant BCL10 nuclear expression in nasal NK/T-cell lymphoma. Blood 102 (2003) 1553-1554
73. Ngo V.N., et al. A loss-of-function RNA interference screen for molecular targets in cancer. Nature 441 (2006) 106-110
74. Lenz G., et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 319 (2008) 1676-1679